BioNTech: Advancing science to help transform cancer and ...
BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.
BioNTech - Wikipedia
BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that …
BioNTech and Co-Founders Announce Plan to Pursue Next ...
Mar 10, 2026 · About BioNTech Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other …
BioNTech founders plan exit to set up new venture, shares ...
Mar 10, 2026 · BioNTech, which developed and sold the COVID-19 shot with Pfizer (PFE.N), said it plans to contribute certain rights and mRNA technologies to the new company on an arm's-length …
BioNTech SE (BNTX) - Yahoo Finance
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including...
BioNTech SE (BNTX) Stock Price & Overview
3 days ago · A detailed overview of BioNTech SE (BNTX) stock, including real-time price, chart, key statistics, news, and more.
BioNTech founders step down to start new venture - dw.com
Mar 10, 2026 · The husband-and-wife founders of German vaccine company BioNTech announced on Tuesday they would step down to pursue new innovations at a brand new firm.